PIMA541696
Ruplizumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541696-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA541696 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Ruplizumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
BG-9588; hu5c8
Immunogen
Human CD40LG
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA
Concentration
1 mg/mL
Formulation
PBS with no preservative; pH 7.5
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Ruplizumab is a humanized monoclonal antibody used as an immunosuppressive pharmaceutical and is a component of Antova
- Ruplizumab is an anti-CD40L monoclonal antibody
- The binding of CD40 to its ligand, CD40L is a critical element in T cell activation
- In systemic lupus erythematosus, CD40L is over-expressed on T cells, B cells and monocytes.
Compare Similar Items
Show Difference
Antigen: Ruplizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BG-9588; hu5c8
Immunogen: Human CD40LG
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Ruplizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BG-9588; hu5c8
Immunogen:
Human CD40LG
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Daclizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BIIB019; DAC HYP
Immunogen: Human IL2RA
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.73 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Daclizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BIIB019; DAC HYP
Immunogen:
Human IL2RA
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.73 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Epratuzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: 90Y-DOTA-hLL2; 90Y-epratuzumab tetraxetan; 90Y-hLL2; AMG-412; hLL2
Immunogen: Human CD22
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.18 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1
Antigen:
Epratuzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
90Y-DOTA-hLL2; 90Y-epratuzumab tetraxetan; 90Y-hLL2; AMG-412; hLL2
Immunogen:
Human CD22
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.18 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1
Antigen: Fontolizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: HuZAF
Immunogen: Human IFNG
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.39 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1
Antigen:
Fontolizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
HuZAF
Immunogen:
Human IFNG
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.39 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1